Phase Ia/Ib trial of Anti-GD2 chimeric monoclonal antibody 14.18 (ch l4.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma

James L. Murray, Eugenie S. Kleinerman, Shu Fang Jia, Michael G. Rosenblum, Omar Eton, Antonio Buzaid, Sewa Legha, Merrick I. Ross, Lora Thompson, Kalpana Mujoo, Paula T. Rieger, Mansoor Saleh, M. B. Khazaeli, Saroj Vadhan-Raj

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase Ia/Ib trial of Anti-GD2 chimeric monoclonal antibody 14.18 (ch l4.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences